Back to list

Ossium Health

World's first frozen bone-marrow bank
Operates the world's first frozen bone-marrow bank for transplants; $158M raised, $300M valuation per Forbes NBDS 2026.
Biotech
Current Valuation
$300M
as of 2026-07
PRIVATE

QL Price

$300M
0% vs last round
QuantLogix's current estimate for Ossium Health, published 2026-08-30 — in line with the last disclosed round of $300M (2026-07).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $300M 2026-07 weight 0.89
How this price has held up
No round has priced for Ossium Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-08-30 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Ossium Health →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Ossium Health, 2026-08-30 (664eb2d0372b55b2). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Ossium Health going public?
No. Ossium Health is private and has not filed to go public. There is no S-1 on file.
What is Ossium Health's valuation in 2026?
Ossium Health is valued at $300M as of Jul 2026. That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Ossium Health filed an S-1?
No public S-1 is on file for Ossium Health.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Total Raised
$158M
IPO Status
Private

Fundraising Status

PrivateTotal raised $158M

Vertical Intelligence — Biotech / Gene Therapy

Registered trials
6
3 active · 1 recruiting
Lead phase
Phase 2
most advanced registered study
Focus areas
Acute Leukemia
Acute Myeloid Leukemia · Acute Biphenotypic Leukemia
Latest trial start
2026-12-01
Name-verified against lead sponsor "Ossium Health, Inc." on ClinicalTrials.gov as of 2026-08-30. Verify on ClinicalTrials.gov ↗

Talent Signal

Hiring data for Ossium Health has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
BiotechHealthcare
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-07. Refreshed quarterly.